Analysis of creatine kinase activity in 504 patients with proximal spinal muscular atrophy types I-III from the point of view of progression and severity.
Mild to moderately elevated creatine kinase (CK) activity is a frequent biochemical finding in proximal spinal muscular atrophy (SMA). In a collaborative study on all types of childhood and juvenile onset SMA, we analysed the CK activity of 504 SMA patients (138 type I, 127 type II, 144 type IIIa, and 95 type IIIb patients). Under the assumption of a lognormal distribution of CK activity as the most appropriate statistical model, CK levels were transformed into logarithms and compared by standard deviation scores = CK-SDS (log). CK activity was statistically different between early and later onset SMA: in SMA I and II, about one-third of patients showed CK-SDS (log) >2 SD, the analysis of the means did not show significant differences. In SMA III, CK-SDS (log) was significantly higher (p < 0.01) than in the two other groups, which was most pronounced in SMA IIIb. More than 90% of SMA IIIb patients showed CK-SDS (log) values >2 vs. 57% in SMA IIIa. As similar values were obtained for a subgroup of 100 patients in whom the diagnosis of autosomal recessive SMA was confirmed by a deletion of the telomeric copy of the survival motor neuron gene, our results can be considered representative for SMA I-III. There was no correlation between CK level and disease duration. The fact that patients were ambulatory or chair-bound had no influence on CK activity in type III SMA. There was no sex influence in SMA I, II and IIIa. The observed higher male values in the group SMA IIIb are most likely the result of a lack of female patients with onset after puberty.
Rudnik-Schöneborn
S
S
Institute for Human Genetics, University of Bonn, Germany. rudnik@humgen.uni-bonn.de
Lützenrath
S
S
Borkowska
J
J
Karwanska
A
A
Hausmanowa-Petrusewicz
I
I
Zerres
K
K
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D003402:Creatine Kinase / Q000378:metabolism*; D018450:Disease Progression; D005260:Female; D017353:Gene Deletion; D006801:Humans; D008297:Male; D009068:Movement / Q000502:physiology; D009134:Muscular Atrophy, Spinal / Q000145:classification / Q000201:enzymology* / Q000503:physiopathology*; D012720:Severity of Illness Index; D012727:Sex Characteristics
D003402:Creatine Kinase